Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Achieve Life Sciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +3 vs. Q4 2022
- Shares held
- 2.47M
- +470.8K (+23.5%) vs. Q4 2022
- Total value
- $16.6M
- +$11.7M (+238.6%) vs. Q4 2022
- New holders
- 8
- 12 more added
- Sold out
- 5
- 6 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACHV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $538.7M |
| Q1 2026 | 81 | $63.6M |
| Q4 2025 | 77 | $115.3M |
| Q3 2025 | 66 | $48.9M |
| Q2 2025 | 66 | $59.3M |
| Q1 2025 | 72 | $38.4M |
| Q4 2024 | 70 | $57.5M |
| Q3 2024 | 64 | $81.2M |
| Q2 2024 | 56 | $78.4M |
| Q1 2024 | 41 | $64.9M |
| Q4 2023 | 29 | $11.2M |
| Q3 2023 | 35 | $13.4M |
| Q2 2023 | 39 | $18.6M |
| Q1 2023 | 31 | $16.6M |
| Q4 2022 | 28 | $4.90M |
| Q3 2022 | 28 | $7.00M |
| Q2 2022 | 31 | $9.97M |
| Q1 2022 | 33 | $14.6M |
| Q4 2021 | 29 | $14.9M |
| Q3 2021 | 32 | $15.2M |
| Q2 2021 | 29 | $17.5M |
| Q1 2021 | 16 | $11.7M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Achieve Life Sciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Shay Capital LLC | 480,000 | $3.26M | 1.35% | +140,000+41.2% | Added |
| Vanguard Group Inc | 419,384 | $2.85M | 0.00% | +79,146+23.3% | Added |
| Long Focus Capital Management, LLC | 313,220 | $2.13M | 0.34% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 180,483 | $1.23M | 0.00% | +95,118+111.4% | Added |
| Ikarian Capital, LLC | 174,714 | $989.5K | 0.41% | +174,714 | New |
| LPL Financial LLC | 143,900 | $978.5K | 0.00% | −4,400−3.0% | Reduced |
| Group One Trading, L.P. | 137,246 | $933.3K | 0.04% | +87,924+178.3% | Added |
| Perkins Capital Management Inc | 137,212 | $933.0K | 0.88% | −80,888−37.1% | Reduced |
| Wells Fargo & Company | 124,523 | $846.8K | 0.00% | −1,447−1.1% | Reduced |
| Raymond James & Associates | 104,282 | $709.1K | 0.00% | +15,033+16.8% | Added |
| Diametric Capital, LP | 46,399 | $315.5K | 0.15% | +26,496+133.1% | Added |
| Renaissance Technologies LLC | 41,600 | $283.0K | 0.00% | +2,400+6.1% | Added |
| Northern Trust Corp | 31,905 | $217.0K | 0.00% | +15,461+94.0% | Added |
| State Street Corp | 27,416 | $186.4K | 0.00% | +4,700+20.7% | Added |
| Walleye Capital LLC | 25,073 | $170.5K | 0.00% | +25,073 | New |
| Prelude Capital Management, LLC | 15,220 | $103.5K | 0.01% | +3,375+28.5% | Added |
| BlackRock Inc. | 12,854 | $87.4K | 0.00% | −1,227−8.7% | Reduced |
| Beaumont Financial Advisors, LLC | 12,000 | $81.6K | 0.01% | +12,000 | New |
| Bank of New York Mellon Corp | 11,672 | $79.4K | 0.00% | +11,672 | New |
| Belvedere Trading LLC | 9,913 | $67.4K | 0.03% | +9,913 | New |
| Morgan Stanley | 3,800 | $25.8K | 0.00% | −9,747−71.9% | Reduced |
| Tower Research Capital LLC (TRC) | 3,646 | $25.0K | 0.00% | +1,570+75.6% | Added |
| Stephens Consulting, LLC | 3,000 | $20.4K | 0.01% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,543 | $17.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,493 | $17.0K | 0.00% | −48,253−95.1% | Reduced |
| Belpointe Asset Management LLC | 2,000 | $13.6K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,527 | $10.0K | 0.00% | +1,458+2,113.0% | Added |
| Cutler Group LP | 1,100 | $7.00K | 0.00% | +1,100 | New |
| UBS Group AG | 726 | $4.94K | 0.00% | +726 | New |
| Godsey & Gibb Associates | 453 | $3.08K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 250 | $1.70K | 0.00% | +250 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −30,422−100.0% | Sold out |
| Clearline Capital LP | 0 | $0 | 0.00% | −27,156−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,755−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,031−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −16−100.0% | Sold out |